Invention Publication
- Patent Title: HETEROCYCLIC COMPOUND
-
Application No.: US18635839Application Date: 2024-04-15
-
Publication No.: US20240343721A1Publication Date: 2024-10-17
- Inventor: Masahiro ITO , Hideyuki SUGIYAMA , Takeshi YAMAMOTO , Keiko KAKEGAWA , Jinxing LI , Junsi WANG , Takahito KASAHARA , Masato YOSHIKAWA
- Applicant: Takeda Pharmaceutical Company Limited
- Applicant Address: JP Osaka
- Assignee: Takeda Pharmaceutical Company Limited
- Current Assignee: Takeda Pharmaceutical Company Limited
- Current Assignee Address: JP Osaka
- Priority: JP 19177815 2019.09.27
- The original application number of the division: US17952546 2022.09.26
- Main IPC: C07D413/14
- IPC: C07D413/14 ; A61P25/28 ; C07D413/10
Abstract:
The present invention provides a heterocyclic compound having a HDAC6 inhibitory action, which is useful for the treatment of central nervous system diseases including neurodegenerative diseases, and the like, and a medicament comprising the compound. The present invention relates to a compound represented by the formula (I):
wherein each symbol is as defined in the description, or a salt thereof.
wherein each symbol is as defined in the description, or a salt thereof.
Information query
